The hepatoprotective effect of basic curcumin and bis (tetrachlorocuprate-lysine) combined with ascorbate against ferric nitrilotriacetate (Fe-NTA) and chloroform induced hepatic carcinogenesis in rats was evaluated. One hundred rats were divided into five equal groups. Normal control group, carcinogenic (Fe-NTA: 9 mg Fe/kg b.wt. i.p.) and chloroform (150 mg/ kg b.wt. orally)-induced group, curcumin group (400 mg/kg. b.wt. orally), tetrachlorocuprate-lysine (25 mg/kg. b. wt. s.c.) and ascorbate (500 mg/kg. b. wt. orally) group and a mixture group (composed of curcumin, tetrachlorocuprate-lysine and ascorbate). Blood samples and liver tissue specimens were collected at the end of experiment (4 months) for determination of the following parameters: activities of serum malondialdehyde (MDA), reduced glutathione (GSH), tissue catalase, myeloperoxidase (MPO), Tumor necrosis factor-α (TNF-α), interleukin-1, nuclear factor kappaB65 (NFkB65) and caspase-3. The obtained results showed that injection of carcinogen caused a significant elevation in the MDA, MPO and immunological markers levels, and significant reduction in the reduced glutathione, and catalase compared to the control group. Compared to carcinogenic group, rats administered with the treated compounds resulted in a significant reduction of MDA, MPO and immunological markers levels, and increased in reduced glutathione and catalase activity. These results concluded that basic curcumin, tetrachlorocuprate-lysine and ascorbate exert chemopreventative effect against hepatocellular carcinoma.